| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/19/2004 | CA2494908A1 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494252A1 Psmcs as modifiers of the rb pathway and methods of use |
| 02/18/2004 | EP1192156B1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
| 02/18/2004 | EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors |
| 02/18/2004 | CN1476429A EP4 receptor selective agonists in treatment of osteoporosis |
| 02/18/2004 | CN1476331A Method and preparations having effect agaist allergic symptoms |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/18/2004 | CN1138778C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/18/2004 | CN1138535C Pharmaceutical compositions contg. effervescent acid -base couple |
| 02/18/2004 | CN1138532C Pharmaceutical aerosol composition |
| 02/17/2004 | US6693111 Indole-2,3-dione-3-oxime derivatives |
| 02/17/2004 | US6692770 Suitable for parenteral administration, preferably via injection comprising amylopectin |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/12/2004 | WO2004012683A2 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | WO2004012681A2 Cancer vaccines containing epitopes of oncofetal antigen |
| 02/12/2004 | WO2004012680A2 Lipid-drug complexes in reversed liquid and liquid crystalline phases |
| 02/12/2004 | WO2004012658A2 Method and device for protein delivery into cells |
| 02/12/2004 | WO2004012657A2 Beta-glucan containing composites, methods for manufacturing and for using such composites |
| 02/12/2004 | WO2004012655A2 Anti-microbial compositions and methods of using same |
| 02/12/2004 | WO2003090683A3 Mixing device for surgical sealants, and method thereof |
| 02/12/2004 | WO2003088909A3 Methods for modulating phototoxicity |
| 02/12/2004 | WO2003010159A8 Piperidine derivatives as nmda receptor antagonists |
| 02/12/2004 | US20040029927 Oral administering of tablet of triprolidine |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | US20040028655 Tissue engineering; drug delivery; fiber with hollow bore |
| 02/12/2004 | CA2495447A1 Anti-microbial compositions and methods of using same |
| 02/12/2004 | CA2494837A1 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | CA2493745A1 Method and device for protein delivery into cells |
| 02/11/2004 | EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/11/2004 | CN1474685A Polymeric delivery formulations of leuprolide with improved efficacy |
| 02/11/2004 | CN1474684A Cosmetic method of treating skin |
| 02/11/2004 | CN1137877C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in in urinary lithasis |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689761 Compound j, nucleoside analog hiv reverse transcriptase inhibitor 3tc and azt |
| 02/10/2004 | US6689758 Treating wounds; using an early growth response-1 transcription factor polypeptide or fragment |
| 02/10/2004 | CA2134196C Pharmaceutical preparation and process for its manufacture |
| 02/05/2004 | WO2004010953A2 Implantable artificial organ devices |
| 02/05/2004 | WO2004010947A2 Humanized antibodies against human 4-1bb |
| 02/05/2004 | WO2004010934A2 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 02/05/2004 | WO2004010923A2 Delivering compounds to the brain by modifying properties of the bbb and cerebral circulation |
| 02/05/2004 | WO2003080580A3 Quinoline derivatives and their use as 5-ht6 ligands |
| 02/05/2004 | WO2003074062A3 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 02/05/2004 | WO2003059292A3 Composition and method for maintaining non-enveloped viral vectors |
| 02/05/2004 | US20040024363 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 02/05/2004 | US20040024307 Para-hydrogen labeled agents and their use in magnetic resonance imaging |
| 02/05/2004 | US20040024197 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 02/05/2004 | US20040024063 Fatty acid analogues for the treatment of cancer |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023955 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 02/05/2004 | US20040023899 Extending the release times and lowering the toxicity of pharmacologically active compounds. The compounds comprise a salt of the pharmacologically active compound with a lipophilic counterion and a pharmaceutically acceptable water |
| 02/05/2004 | US20040023898 Single dose azithromycin |
| 02/05/2004 | US20040023391 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040022883 Persea americana var. drymifolia leaves (avocado) |
| 02/05/2004 | US20040022817 Non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered |
| 02/05/2004 | US20040022750 Method of making enhanced efficacy antiperspirant actives |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386921A1 Intermediates |
| 02/04/2004 | EP1386917A1 Intermediates |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1386909A1 Cyclopropane amines |
| 02/04/2004 | EP1386614A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
| 02/04/2004 | EP1385868A2 Steroidal derivatives |
| 02/04/2004 | CN1471981A Surface treatment for SARS lungs bacteria infection |
| 02/04/2004 | CN1471953A Medicinal plant composition for treating AIDS patient |
| 02/04/2004 | CN1136918C Vaccines |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6685947 Derived from canine distemper virus |
| 01/31/2004 | CA2425568A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
| 01/29/2004 | WO2004009776A2 TREATMENT OF TNFα RELATED DISORDERS |
| 01/29/2004 | WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | WO2004009035A2 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | WO2004009032A2 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 01/29/2004 | WO2004009029A2 Compositions and methods for treating and preventing infection |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2004009014A2 Systems and methods for monitoring and enabling use of a medical instrument |
| 01/29/2004 | WO2003051284A3 Method and device for the delivery of a substance |
| 01/29/2004 | WO2003049705A3 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/29/2004 | WO2003035001A3 Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity |
| 01/29/2004 | US20040019207 Amines such as 8-Benzyl-3-(3-pyridyl)-8-azabicyclo(3.2.1) oct-2-ene, that bind to nicotinic acetocholine receptors, used for prophylaxis of nervous system disorders, as analgesis, antiinflammatory agents and drug abuse |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019102 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb) |
| 01/29/2004 | US20040019100 HMG CoA-reductase inhibitors |
| 01/29/2004 | US20040019063 Nitrogen compounds such as 4-(7-Hydroxy-1,3-dioxo-tetrahydro-pyrrolo(1,2-c)imidazol-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carbonitrile, used for prophylaxis of muscular disorders; aging |
| 01/29/2004 | US20040019056 Anititumoral analogs of et-743 |
| 01/29/2004 | US20040019011 Treatment of conitions and disease |
| 01/29/2004 | US20040018981 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 01/29/2004 | US20040018515 Quantitative analysis; using nucleic acids; binding to aptamer |
| 01/29/2004 | US20040018257 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1 |
| 01/29/2004 | US20040018234 Four different dosage forms, two antibiotics inhibiting protein and non-protein synthesis, one comprising immediate release and sustained release, the other three has sustained release forms, twenty-four hour period; bacterial infections |
| 01/29/2004 | US20040018228 Compositions and methods for reducing scar tissue formation |
| 01/29/2004 | US20040018204 Compositions and methods for WT1 specific immunotherapy |
| 01/29/2004 | CA2803741A1 Treatment of psoriasis with human anti-tnf alpha antibody |
| 01/29/2004 | CA2493766A1 Systems and methods for monitoring and enabling use of a medical instrument |
| 01/29/2004 | CA2493182A1 Compositions and methods for treating and preventing infection |